Cargando…

Glucosuria Interferes With Measurement of Effective Renal Plasma Flow Using para-Aminohippuric Acid, With a Focus on SGLT2 Inhibitors

Detalles Bibliográficos
Autores principales:	Scholtes, Rosalie A., Nguyen, Isabel T.N., van Bommel, Erik J.M., Willekes, Nel, van Nieuwenhuijzen, Melanie, van Raalte, Daniël H., Joles, Jaap A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609950/ https://www.ncbi.nlm.nih.gov/pubmed/33163726 http://dx.doi.org/10.1016/j.ekir.2020.09.002

Ejemplares similares

Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors
por: Scholtes, Rosalie A., et al.
Publicado: (2021)

Prolonged glucosuria and relapse of diabetic ketoacidosis related to SGLT2‐inhibitor therapy
por: Westcott, Gregory P., et al.
Publicado: (2020)

Tubuloglomerular Feedback in Renal Glucosuria: Mimicking Long-term SGLT-2 Inhibitor Therapy
por: Neuwirt, Hannes, et al.
Publicado: (2019)

Basal glucosuria in cats
por: Zeugswetter, Florian Karl, et al.
Publicado: (2018)

Glucosuria in Paludal Fever
Publicado: (1860)

Prolonged Glucosuria With Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Case Report and Review of Literature
por: Aggarwal, Ankita, et al.
Publicado: (2020)

Pharmacokinetics of p-Aminohippuric Acid and Inulin in Rabbits with Aristolochic Acid Nephropathy
por: Tseng, Chiao-Shih, et al.
Publicado: (2011)

Hypouricaemia and hyperuricosuria in familial renal glucosuria
por: Aires, Inês, et al.
Publicado: (2013)

Glucosuria and Prognosis in Acute Kidney Injury
por: Beenken, Andrew
Publicado: (2019)

Glucosuria Predicts the Severity of Puumala Hantavirus Infection
por: Tietäväinen, Johanna, et al.
Publicado: (2019)

Case report: Identification of three novel compound heterozygous SGLT2 variants in three Chinese pediatric patients with familial renal glucosuria
por: Huang, Huimei, et al.
Publicado: (2022)

THE INTRARENAL DISTRIBUTION OF TRITIATED PARA-AMINOHIPPURIC ACID DETERMINED BY A MODIFIED TECHNIQUE OF SECTION FREEZE-DRY RADIOAUTOGRAPHY
por: Bordier, Betrand, et al.
Publicado: (1970)

The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists
por: van Baar, Michaël J. B., et al.
Publicado: (2019)

Greater Dose-Ranging Effects on A1C Levels Than on Glucosuria With LX4211, a Dual Inhibitor of SGLT1 and SGLT2, in Patients With Type 2 Diabetes on Metformin Monotherapy
por: Rosenstock, Julio, et al.
Publicado: (2015)

Glucosuria as an early marker of late-onset sepsis in preterms: a prospective cohort study
por: Bekhof, Jolita, et al.
Publicado: (2015)

Spectrophotometric and colorimetric determination of gallium (III) with p-aminohippuric acid-functionalized citrate capped gold nanoparticles
por: AVAN, Asiye Aslıhan
Publicado: (2021)

Skin microvascular function and renal hemodynamics in overweight patients with type 2 diabetes: A cross‐sectional study
por: Bouman, Emma J., et al.
Publicado: (2021)

Simultaneous Measurement of Glomerular Filtration Rate, Effective Renal Plasma Flow and Tubular Secretion in Different Poultry Species by Single Intravenous Bolus of Iohexol and Para-Aminohippuric Acid
por: Stroobant, Lenka, et al.
Publicado: (2020)

Significant association between glycemic status and increased estimated postglomerular resistance in nondiabetic subjects – study of inulin and para-aminohippuric acid clearance in humans
por: Yasumoto, Mari, et al.
Publicado: (2015)

Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes
por: van der Hoek, Sjoukje, et al.
Publicado: (2023)

Reprogramming: A Preventive Strategy in Hypertension Focusing on the Kidney
por: Tain, You-Lin, et al.
Publicado: (2015)

Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin
por: Kelmenson, Daniel A., et al.
Publicado: (2017)

Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial
por: Scholtes, Rosalie A., et al.
Publicado: (2022)

A novel SLC5A2 heterozygous variant in a family with familial renal glucosuria
por: Hatano, Maho, et al.
Publicado: (2022)

Effects of SGLT2 Inhibitors beyond Glycemic Control—Focus on Myocardial SGLT1
por: Sayour, Alex Ali, et al.
Publicado: (2021)

Plasma uric acid and renal haemodynamics in type 2 diabetes patients
por: Suijk, Danii LS, et al.
Publicado: (2019)

Novel SLC5A2 mutation contributes to familial renal glucosuria: Abnormal expression in renal tissues
por: Yu, Lei, et al.
Publicado: (2016)

SLC5A2 mutations, including two novel mutations, responsible for renal glucosuria in Chinese families
por: Yu, Lei, et al.
Publicado: (2020)

Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41:1543–1556
por: van Baar, Michaël J.B., et al.
Publicado: (2019)

Estudio de la eficacía del método del 3-5 dinitrosalicilico en la determinación de glucosuria
por: Campos Ortega, Eloisa Saturnina
Publicado: (1987)

Albumin is an interface between blood plasma and cell membrane, and not just a sponge
por: van de Wouw, Jens, et al.
Publicado: (2021)

8‐Aminoguanine Induces Diuresis, Natriuresis, and Glucosuria by Inhibiting Purine Nucleoside Phosphorylase and Reduces Potassium Excretion by Inhibiting Rac1
por: Jackson, Edwin K., et al.
Publicado: (2018)

Dissecting recipient from donor contribution in experimental kidney transplantation: focus on endothelial proliferation and inflammation
por: Papazova, Diana A., et al.
Publicado: (2018)

Novel natural and synthetic inhibitors of solute carriers SGLT1 and SGLT2
por: Oranje, Paul, et al.
Publicado: (2019)

Renal sinus fat and renal hemodynamics: a cross-sectional analysis
por: Spit, Karlinde A., et al.
Publicado: (2019)

Clinical and genetic analysis in a patient with primary renal glucosuria: Identification of a novel mutation in the SLC5A2 gene
por: LEE, YONG-WHA
Publicado: (2013)

A recurrent deletion in the SLC5A2 gene including the intron 7 branch site responsible for familial renal glucosuria
por: Zhao, Xiangzhong, et al.
Publicado: (2016)

The effects of dapagliflozin on cardio‐renal risk factors in patients with type 2 diabetes with or without renin‐angiotensin system inhibitor treatment: a post hoc analysis
por: Scholtes, Rosalie A., et al.
Publicado: (2019)

Acquired renal glucosuria in an undifferentiated connective tissue disease patient with a SLC5A2 heterozygous mutation: A case report
por: Gu, Xiangchen, et al.
Publicado: (2018)

Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin
por: Haas, B, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tp2icnhvp2mftoveqpttut49ml